Professor of Medicine
University of California, San Diego
La Jolla, California, United States
Ori Ben-Yehuda, MD, FACC is Professor of Medicine at UCSD and the Director of the Cardiovascular Outcomes Group (CVOG) at UCSD. A graduate of Tel Aviv University, he completed his fellowship in cardiology at the University of California, San Diego. From 1997 to 2011 he was the Director of the Coronary Care Unit at UCSD He also served as the Deputy Editor of the Journal of the American College of Cardiology and is presently the Editor in Chief of Coronary Artery Disease. From 2013-2022 Dr. Ben-Yehuda was the Executive Director of the Clinical Trials Center at the Cardiovascular Research Foundation. Dr. Ben-Yehuda also serves as the CMO of Bioventrix, Inc. and is actively involved in multiple trials in structural heart disease.
Saturday, February 25, 2023
11:20 AM – 11:50 AM ET
Disclosure(s): Bioventrix, Inc: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing), Salary (Ongoing); Cardiovalve: Consultant (Ongoing)
Saturday, February 25, 2023
11:30 AM – 11:50 AM ET
Disclosure(s): Bioventrix, Inc: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing), Salary (Ongoing); Cardiovalve: Consultant (Ongoing)
Saturday, February 25, 2023
4:30 PM – 5:30 PM ET
Disclosure(s): Bioventrix, Inc: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing), Salary (Ongoing); Cardiovalve: Consultant (Ongoing)
Tuesday, February 28, 2023
8:59 AM – 9:30 AM ET
Disclosure(s): Bioventrix, Inc: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing), Salary (Ongoing); Cardiovalve: Consultant (Ongoing)
Tuesday, February 28, 2023
10:30 AM – 10:42 AM ET
Disclosure(s): Bioventrix, Inc: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing), Salary (Ongoing); Cardiovalve: Consultant (Ongoing)
Tuesday, February 28, 2023
11:50 AM – 11:58 AM ET
Disclosure(s): Bioventrix, Inc: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing), Salary (Ongoing); Cardiovalve: Consultant (Ongoing)
Tuesday, February 28, 2023
9:43 AM – 9:51 AM ET
Disclosure(s): Bioventrix, Inc: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing), Salary (Ongoing); Cardiovalve: Consultant (Ongoing)
Tuesday, February 28, 2023
10:07 AM – 10:30 AM ET
Disclosure(s): Bioventrix, Inc: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing), Salary (Ongoing); Cardiovalve: Consultant (Ongoing)